Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Generally healthy, men and women, aged 18 to 65.
Hospitalization because of an acute exacerbation of schizophrenia with a diagnosis of schizophrenia established greater than 1 year.
Ability to remain hospitalized for the duration of the screening period and for 4 weeks of double-blind treatment.
You may not be if
Current Axis I primary psychiatric diagnosis other than schizophrenia (DSM-IV-TR criteria).
Current diagnosis or history of substance abuse or dependence (DSM-IV-TR criteria), including alcohol (except for nicotine), within 3 months before baseline (day -1).
Subjects taking high or chronic doses of benzodiazepine at the screening evaluation who, in the investigator's judgment, would be likely to have severe withdrawal symptoms upon discontinuation.
